Sanofi Makes Big Strides In Eradicating Sleeping Sickness
Acoziborole Cured 95% of People With Late-Stage Disease
Executive Summary
The positive Phase II/III results for acoziborole have led researchers to claim that the goal of eliminating sleeping sickness by 2030 is now very much a reality.